Dr. Reddy’s Laboratories Ltd has launched ezetimibe and simvastatin tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg a therapeutic equivalent generic version of Vytorin (ezetimibe and simvastatin) tablets in the United States market, approved by the US Food and Drug Administration (FDA). Dr. Reddy’s is among the first companies to launch the generic product in the US market.
The Vytorin brand had US sales of approximately $678 million MAT for the most recent twelve months ended in February 2017 according to IMS Health. Dr. Reddy’s ezetimibe and simvastatin tablets, 10 mg/10 mg, 10 mg/20mg, 10 mg/40 mg, and 10 mg/80 mg, are available in bottle count sizes of 30, 90 and 1000.
